
Neurent Medical, a developer of treatments for chronic inflammatory sino-nasal diseases, has secured $25 million in Series B financing. The investors included LSP and Atlantic Bridge.
Source: Press Release
Neurent Medical, a developer of treatments for chronic inflammatory sino-nasal diseases, has secured $25 million in Series B financing.
Neurent Medical, a developer of treatments for chronic inflammatory sino-nasal diseases, has secured $25 million in Series B financing. The investors included LSP and Atlantic Bridge.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination